Increased concentration of the CSF Tau protein and its phosphorylated form in the late juvenile metachromatic leukodystrophy form: A case report

Journal of Neural Transmission

Volumn 119, Issue 7, 2012, Pages 759-762

  Tarasiuk, Joanna ^a   Kapica Topczewska, Katarzyna ^a   Kułakowska, Alina ^a   Halicka, Dorota ^a   Drozdowski, Wiesław ^a   Kornhuber, Johannes ^b   Lewczuk, Piotr ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Arylsulfatase A; Cerebrospinal fluid; Lysosomal storage diseases; Metachromatic leukodystrophy

Indexed keywords

ALBUMIN; AMYLOID BETA PROTEIN[1-42]; CEREBROSIDE SULFATASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TAU PROTEIN; VALPROIC ACID;

ADULT; ARTICLE; BRAIN ATROPHY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; COGNITIVE DEFECT; DEMENTIA; ENZYME ACTIVITY; FACIAL NERVE PARALYSIS; HUMAN; METACHROMATIC LEUKODYSTROPHY; MOTOR PERFORMANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SEIZURE; SPEECH DISORDER; WORKING MEMORY;

ADULT; AMYLOID BETA-PEPTIDES; BRAIN; HUMANS; LEUKODYSTROPHY, METACHROMATIC; MALE; NERVE FIBERS, MYELINATED; PEPTIDE FRAGMENTS; PHOSPHORYLATION; TAU PROTEINS;

EID: 84863487308     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-012-0826-7     Document Type: Article

References (20)

1. Auer IA, Schmidt ML, Lee VM, Curry B, Suzuki K, Shin RW, Pentchev PG, Carstea ED, Trojanowski JQ (1995) Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease. Acta Neuropathol 90:547-551
2. Austin JH (1960) Metachromatic form of diffuse cerebral sclerosis. III. Significance of sulfatide and other lipid abnormalities in white matter and kidney. Neurology 10:470-483
3. Baumann N, Turpin JC, Lefevre M, Colsch B (2002) Motor and psycho-cognitive clinical types in adult metachromatic leukodystrophy: genotype/phenotype relationships? J Physiol Paris 96:301-306
4. Black DN, Taber KH, Hurley RA (2003) Metachromatic leukodystrophy: a model for the study of psychosis. J Neuropsychiatry Clin Neurosci 15:289-293
5. Consiglio A, Quattrini A, Martino S, Bensadoun JC, Dolcetta D, Trojani A, Benaglia G, Marchesini S, Cestari V, Oliverio A, Bordignon C, Naldini L (2001) In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice. Nat Med 7:310-316
6. Finelli PF (1985) Metachromatic leukodystrophy manifesting as a schizophrenic disorder: computed tomographic correlation. Ann Neurol 18:94-95
7. Gilman S, Koller M, Black RS, Jenkins L, Griffith SG, Fox NC, Eisner L, Kirby L, Rovira MB, Forette F, Orgogozo JM (2005) Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology 64:1553-1562
8. Greene H, Hug G, Schubert WK (1967) Arylsulfatase A in the urine and metachromatic leukodystrophy. J Pediatr 71:709-711
9. Hohenschutz C, Friedl W, Schlör KH, Waheed A, Conzelmann E, Sandhoff K, Propping P (1988) Probable metachromatic leukodystrophy/pseudodeficiency compound heterozygote at the arylsulfatase A locus with neurological and psychiatric symptomatology. Am J Med Genet 31:169-175
10. Kihara H (1982) Genetic heterogeneity in metachromatic leukodystrophy. Am J Hum Genet 34:171-181
11. Lewczuk P, Esselmann H, Bibl M, Beck G, Maler JM, Otto M, Kornhuber J, Wiltfang J (2004a) Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature. J Mol Neurosci 23:115-122
12. Lewczuk P, Esselmann H, Otto M, Maler JM, Henkel AW, Henkel MK, Eikenberg O, Antz C, Krause WR, Reulbach U, Kornhuber J, Wiltfang J (2004b) Neurochemical diagnosis of Alzheimer's dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau. Neurobiol Aging 25:273-281
13. Lewczuk P, Zimmermann R, Wiltfang J, Kornhuber J (2009) Neurochemical dementia diagnostics: a simple algorithm for interpretation of the CSF biomarkers. J Neural Transm 116: 1163-1167
14. Lewczuk P, Kornhuber J (2011) Neurochemical dementia diagnostics in Alzheimer's disease: where are we now and where are we going? Expert Rev Proteomics 8:447-458
15. Martin PL, Carter SL, Kernan NA, Sahdev I, Wall D, Pietryga D, Wagner JE, Kurtzberg J (2006) Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant 12:184-194
16. Mattsson N, Savman K, Osterlundh G, Blennow K, Zetterberg H (2010) Converging molecular pathways in human neural development and degeneration. Neurosci Res 66:330-332
17. Mattsson N, Zetterberg H, Bianconi S, Yanjanin NM, Fu R, Mansson JE, Porter FD, Blennow K (2011) Gamma-secretase-dependent amyloid-beta is increased in Niemann-Pick type C: a crosssectional study. Neurology 76:366-372
18. Polten A, Fluharty AL, Fluharty CB, Kappler J, von Figura K, Gieselmann V (1991) Molecular basis of different forms of metachromatic leukodystrophy. N Engl J Med 324:18-22
19. Sjogren M, Vanderstichele H, Agren H, Zachrisson O, Edsbagge M, Wikkelso C, Skoog I, Wallin A, Wahlund LO, Marcusson J, Nagga K, Andreasen N, Davidsson P, Vanmechelen E, Blennow K (2001) Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin Chem 47:1776-1781
20. Webster HD (1962) Schwann cell alterations in metachromatic leukodystrophy: preliminary phase and electron microscopic observations. J Neuropathol Exp Neurol 21:534-554